Rotigotine safety in real-world settings: a pharmacovigilance study using FAERS data
Our findings, which align with the established safety profile of rotigotine, reveal the presence of unexpected serious AEs and emphasize the importance of continued vigilance in post-marketing surveillance.
Authors
- Jiaxin Zheng (ORCID: https://orcid.org/0000-0001-5943-0935)
- Yang-xin Qiu (ORCID: https://orcid.org/0000-0002-2430-2666)
- Shuihua Xie
- Chaoxiang Zhang
- Jing He (ORCID: https://orcid.org/0000-0001-6488-1052)
- Hao Zhang (ORCID: https://orcid.org/0000-0002-8772-388X)
- Jianglong Tu (ORCID: https://orcid.org/0000-0002-8057-3153)
Institutions
- Jiangxi University of Traditional Chinese Medicine (CN)
Publication Details
- Journal
- BMC Pharmacology and Toxicology
- Published
- 2025-03-31
- DOI
- https://doi.org/10.1186/s40360-025-00911-5
- Primary Topic
- Bipolar Disorder and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00